Literature DB >> 6225522

Role of calcium in triggering the release of transmitters at the neuromuscular junction.

C J Duncan.   

Abstract

Calcium ions have a key role in triggering the release of packaged transmitter at the amphibian neuromuscular junction and of the chromaffin granules at the adrenal medulla. It is suggested that (i) proteins on the vesicle and plasma membranes are of particular importance in promoting membrane fusion and exocytosis (ii) they may be divalent cation-stimulated ATPases, which form the calcium-binding sites or have a specific calcium-binding protein in close molecular apposition (iii) these ATPases in synaptic vesicles and chromaffin granules also generate a protonmotive force which is associated with the uptake of transmitter (iv) the osmotic properties of the vesicle may be important during fission, but it is not suggested that chemiosmotic effects are involved in Ca2+-triggered fusion (v) the action of calcium is markedly co-operative (vi) the adrenal medullary cell and the n.m.j. may differ in the Ca2+-binding site; there is evidence for the involvement of calmodulin in granule-plasmalemma fusion in the chromaffin cells, but not at present (surprisingly) for a role of this Ca2+-binding protein at the n.m.j. (vii) exocytosis requires MgATP (viii) phosphorylation of the ATPase may well be involved; phosphorylation via cAMP does not seem to be involved in fusion in either system (ix) the ATPase may undergo configurational changes during exocytosis and is markedly sensitive to the physical state of its phospholipid environment and to the oxidation of its -SH groups.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6225522     DOI: 10.1016/0143-4160(83)90032-5

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  1 in total

1.  Calmodulin increases transmitter release by mobilizing quanta at the frog motor nerve terminal.

Authors:  Eugen Brailoiu; Michael D Miyamoto; Nae J Dun
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.